NPS PHARMACEUTICALS INC's ticker is P103PS and the CUSIP is 62936P103. A total of 205 filers reported holding NPS PHARMACEUTICALS INC in Q3 2014. The put-call ratio across all filers is 0.66 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2014 | $6,401,000 | -47.5% | 178,960 | -61.8% | 0.76% | +4.0% |
| Q3 2014 | $12,192,000 | -63.4% | 468,945 | -53.5% | 0.73% | -50.4% |
| Q2 2014 | $33,298,000 | -25.8% | 1,007,532 | -32.8% | 1.48% | +23.7% |
| Q1 2014 | $44,895,000 | -32.6% | 1,500,046 | -31.6% | 1.19% | +0.3% |
| Q4 2013 | $66,586,000 | -28.6% | 2,193,213 | -25.2% | 1.19% | -22.9% |
| Q3 2013 | $93,322,000 | +91.6% | 2,933,755 | -9.0% | 1.54% | +135.3% |
| Q2 2013 | $48,696,000 | – | 3,222,836 | – | 0.66% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| HARVEY CAPITAL MANAGEMENT INC | 549,425 | $16,680,000 | 6.89% |
| Opaleye Management Inc. | 205,000 | $5,945,000,000 | 4.67% |
| Rhenman & Partners Asset Management AB | 240,000 | $7,286,000 | 2.85% |
| SECTORAL ASSET MANAGEMENT INC | 1,774,919 | $53,887,000 | 2.32% |
| Eventide Asset Management | 242,700 | $7,368,000 | 2.27% |
| OAK RIDGE INVESTMENTS LLC | 2,713,717 | $82,389,000 | 2.16% |
| First Light Asset Management, LLC | 68,245 | $2,072,000 | 1.76% |
| Broadfin Capital, LLC | 400,000 | $12,144,000 | 1.60% |
| Cupps Capital Management, LLC | 748,175 | $22,714,000 | 1.54% |
| FCG ADVISORS, LLC | 70,651 | $2,145,000 | 1.45% |